Strengthening tight junctions of retinal microvascular endothelial cells by pericytes under normoxia and hypoxia involving angiopoietin-1 signal way

Eye

Volumn 21, Issue 12, 2007, Pages 1501-1510

  Wang, Y L ^a   Hui, Y N ^a   Guo, B ^a   Ma, J X ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; NEUTRALIZING ANTIBODY; OCCLUDIN; PROTEIN ZO1;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL HYPOXIA; CELL MEMBRANE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; GENE EXPRESSION; IMMUNOFLUORESCENCE; MICROVASCULATURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERICYTE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RETINA CELL; RETINA NEOVASCULARIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIGHT JUNCTION; WESTERN BLOTTING;

EID: 37749019976     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702716     Document Type: Article

References (36)

1. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S. Occludin: A novel integral membrane protein localizing at tight junctions. J Cell Biol 1993; 123: 1777-1788.
2. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 1998; 141(7): 1539-1550.
3. Barber AJ, ntonetti DA, Gardner TW. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes: the Penn State Retina Research Group. Invest Ophthalmol Vis Sci 2000; 41: 3541-3568.
4. Lee HS, Namkoong K, Kim DH, Kim KJ, Cheong YH, Kim SS et al. Hydrogen peroxide-induced alterations of tight junction proteins in bovine brain microvascular endothelial Microvasc Res 2004; 68 231-238.
5. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005; 57(2): 173-185.
6. Janzer RC, Lobrinus JA, Dankar P, Juillerat L. Astrocytes secrete a factor inducing the expression of HT7-protein and neurothelin in endothelial cells of chorioallantoic vessels. Adv Exp Med Biol 1993; 331: 217-221.
7. Jeliazkova-Mecheva VV, Bobilya DJ. A porcine astrocyte/endothelial cell co-culture model of the blood-brain barrier. Brain Res Brain Res Protoc 2003; 12: 91-98.
8. D'Amore PA. Capillary growth: A two-cell system. Semin Cancer Biol 1992; 3(2): 49-56.
9. Uemura A, Ogawa M, Hirashima M, Fujiwara T, Koyama S, Takagi H et al. Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J Clin Invest 2002; 110: 1619-1628.
10. Hellstrom M, Gerhardt H, Kalen M, Li X, Eriksson U, Wolburg H et al. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 2001; 153(3): 543-553.
11. Sims DE. Diversity within pericytes. Clin Exp Pharmacol Physiol 2000; 27(10): 842-846.
12. Nambu H, Nambu R, Oshima Y, Hackett SF, Okoye G, Wiegand S et al. Angiopoietin-1 inhibits ocular neovascularization and breakdown of the blood-retinal barrier. Gene Theraphy 2004; 11: 865-873.
13. Gamble JR, Drew J, Trezise L, Underwood A, Parsons M, Kasminkas L et al. Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ Res 2000; 87 7): 603-607.
14. Fischer S, Wobben M, Marti HH, Renz D, Schaper W. Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc Res 2002; 63: 70-80.
15. Behzadian MA, Wang XL, Windsor LJ, Ghaly N, Caldwell RB. increases retinal endothelial cell permeability by increasing MMP-9: Possible role of glial cells in endothelial barrier function. Invest Ophthalmol Vis Sci 2001; 42(3): 853-859.
16. Frye CA, Patrick Jr CW. Isolation and culture of rat microvascular endothelial cells. In vitro Cell Dev Biol Anim 2002; 38(4): 208-212.
17. Capetandes A, Gerritsen ME. Simplified methods for consistent and selective culture of bovine retinal endothelial cells and pericytes. Invest Ophthalmol Vis Sci 1990; 31(9): 1738-1744.
18. Pham I, Uchida T, Planes C, Ware LB, Kaner R, Matthay MA et al. Hypoxia upregulates VEGF expression in alveolar epithelial cells in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol 2002; 283(5): L1133-1142.
19. Brankin B, Campbell M, Canning P, Gardiner TA, Stitt AW. Endostatin modulates VEGF-mediated barrier dysfunction in the retina microvascular endothelium. Exp Eye Res 2005; 81(1): 22-31
20. Grima J, Cheng CY. Testin induction: The role of cyclic 3′, 5′-adenome monophosphate/protein kinase A signaling in the regulation of basal and lonidine-induced testin expression by rat sertoli cells. Biol Reprod 2000; 63(6): 1648-1660
21. Tretiach M, van Driel D, Gillies MC. Transendothelial electrical resistance of bovine capillary endothelial cells is influenced by cell growth patterns. An ultrastructural study. Clin Exp Ophthalmol 2003; 31: 348-353
22. Balabanov P, Dore-Duffy P. Role of the CNS microvascular pericyte in the blood-brain barrier. J Neurosci Res 1998; 53: 637-644.
23. Hirase T, Stiddon JM, Saitou M, Anou-Akatsuka Y, Itoh M, Furuse M et al. Occludin as a possible determinant of tight junction permeability in endothelial cells. J Cell Sci 1997; 110: 1603-1613.
24. McCarthy KM, Skare IB, Stankewich MC, Furuse M, Tsukita S et al. Occludin is a functional component of the tight junction. J Cell Sci 1996; 109: 2287-2293.
25. Nusrat A, Parkos CA, Verkade P, Folov CS, Liang TW, Innis-Whitehouse W et al. Tight junctions are membrane microdomains. J Cell Sci 2000; 113: 1771-1781.
26. Jousen AM, Poulaki V, Tsujikawa A, Qin W, Qaum T, Xu Q et al. Suppression of diabetic retinopathy with angiopoietin-1. Am J Pathol 2002; 160(5): 1683-1693.
27. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V et al. Isolation of angiopoietin, a ligand for the Tie2 receptor by secretion trap expression cloning. Cell 1996; 87(7): 1161-1169.
28. Uemura A, Ogawa M, Hirashima M, Fujiwara T, Koyama S, Takagi H et al. Recombinant angiopoietin1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J Clin Invest 2002; 110: 1619-1628.
29. Dohgu S, Takata F, Yamauchi A, Nakagawa S, Egawa T, Naito M et al. Brain pericytes contribute to the induction and up-regulation of blood-brain barrier functions through transforming growth factor-beta-production. Brain Res 2005; 1038(2): 208-215.
30. Sobue K, Yamamoto N, Yoneda K, Hodgson ME, Yamashiro K, Tsuruoka N et al. Induction of blood-brain barrier properties in immortalized bovine brain endothelial cells by astrocytic factors. Neurosci Res 1999; 35: 155-164.
31. Fischer S, Wobben M, Kleinstuck J, Renz D, Schaper W. Effect of astroglial cells on hypoxia-induced permeability in PBMEC cells. Am J Physiol Cell Physiol 2000; 279: C935-C944.
32. Antonetti DA, Barber AJ, Hollinger LA, Wolpert EB, Gardner TW. Vascular, endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Biol Chem 1999; 274: 23463-23467.
33. Clarke H, Soler AP, Mullin JM. Protein kinase C activation leads to dephosphorylation of occludin and tight junction permeability increase in LLC-PK1 epithelial cell sheets. J Cell Sci 2000; 113: 3187-3196.
34. Traweger A, Fang D, Liu YC, Stelzhammer W, Krizbai IA, Fessler F et al. The tight junction-specific protein occludin is a functional target of the E3 ubiquitin protein ligase itch. J Biol Chem 2002; 277: 10201-10208.
35. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C et al. Angiopoietin-2, natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55-60.
36. Mandriota SJ, Pyke C, Di Sanza C, Quinodoz P, Pittet B, Pepper MS. Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia. Am J Pathol 2000; 156: 2077-2089.